These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Human biomonitoring: state of the art. Angerer J; Ewers U; Wilhelm M Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741 [TBL] [Abstract][Full Text] [Related]
24. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH). Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675 [TBL] [Abstract][Full Text] [Related]
25. Toxicovigilance: a new approach for the hazard identification and risk assessment of toxicants in human beings. Descotes J; Testud F Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):599-603. PubMed ID: 15979670 [TBL] [Abstract][Full Text] [Related]
27. New developments in exposure assessment: the impact on the practice of health risk assessment and epidemiological studies. Nieuwenhuijsen M; Paustenbach D; Duarte-Davidson R Environ Int; 2006 Dec; 32(8):996-1009. PubMed ID: 16875734 [TBL] [Abstract][Full Text] [Related]
28. Challenges to developing countries after joining WTO: risk assessment of chemicals in food. Chen J Toxicology; 2004 May; 198(1-3):3-7. PubMed ID: 15138023 [TBL] [Abstract][Full Text] [Related]
30. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536 [TBL] [Abstract][Full Text] [Related]
31. The application of genetic information for regulatory standard setting under the clean air act: a decision-analytic approach. Cullen AC; Corrales MA; Kramer CB; Faustman EM Risk Anal; 2008 Aug; 28(4):877-90. PubMed ID: 18631305 [TBL] [Abstract][Full Text] [Related]
32. Enhancing the credibility of decisions based on scientific conclusions: transparency is imperative. Schreider J; Barrow C; Birchfield N; Dearfield K; Devlin D; Henry S; Kramer M; Schappelle S; Solomon K; Weed DL; Embry MR Toxicol Sci; 2010 Jul; 116(1):5-7. PubMed ID: 20363830 [TBL] [Abstract][Full Text] [Related]
33. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing. Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E; Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066 [TBL] [Abstract][Full Text] [Related]
34. Modeling exposure to persistent chemicals in hazard and risk assessment. Cowan-Ellsberry CE; McLachlan MS; Arnot JA; Macleod M; McKone TE; Wania F Integr Environ Assess Manag; 2009 Oct; 5(4):662-79. PubMed ID: 19552503 [TBL] [Abstract][Full Text] [Related]
35. [Human ecology and interdisciplinary cooperation for primary prevention of environmental risk factors for public health]. Dobrowolski JW Przegl Lek; 2007; 64 Suppl 4():35-41. PubMed ID: 18540323 [TBL] [Abstract][Full Text] [Related]
36. [Proposal of a computerized system for chemical risk management at biomedical laboratories]. Temponi M; Neri G; Apostoli P G Ital Med Lav Ergon; 2000; 22(2):122-9. PubMed ID: 10911553 [TBL] [Abstract][Full Text] [Related]
37. Identification of priorities for chemical hazard control. Indulski JA; Krajewski JA Med Pr; 1987; 38(2):132-42. PubMed ID: 3626851 [TBL] [Abstract][Full Text] [Related]
38. Critical evaluation of the cancer risk of dibromochloropropane (DBCP). Clark HA; Snedeker SM J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2005; 23(2):215-60. PubMed ID: 16291528 [TBL] [Abstract][Full Text] [Related]